FCMI

Foresite Capital Management III Portfolio holdings

AUM $37.9M
This Quarter Return
+50.06%
1 Year Return
-6.87%
3 Year Return
+443.49%
5 Year Return
+535.97%
10 Year Return
–
AUM
$178M
AUM Growth
+$178M
Cap. Flow
-$149M
Cap. Flow %
-83.47%
Top 10 Hldgs %
100%
Holding
14
New
–
Increased
1
Reduced
7
Closed
4

Top Buys

1
MYOK
MyoKardia, Inc. Common Stock
MYOK
$2.03M

Top Sells

1
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
$45.1M
2
BPMC
Blueprint Medicines
BPMC
$41.1M
3
ASND icon
Ascendis Pharma
ASND
$26.5M
4
AIMT
Aimmune Therapeutics, Inc.
AIMT
$12.8M
5
EPZM
Epizyme, Inc
EPZM
$7.65M

Sector Composition

1 Healthcare 47.41%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
AERI
1
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
$56.8M 31.84% 2,350,477 – –
IMMU
2
DELISTED
Immunomedics Inc
IMMU
$37M 20.75% 1,750,000 -206,362 -11% -$4.37M
MYOK
3
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$23.8M 13.34% 326,482 +27,816 +9% +$2.03M
EPZM
4
DELISTED
Epizyme, Inc
EPZM
$16.9M 9.48% 687,427 -310,851 -31% -$7.65M
BOLD
5
DELISTED
Audentes Therapeutics, Inc
BOLD
$13.9M 7.82% 233,067 -82,264 -26% -$4.92M
XLRN
6
DELISTED
Acceleron Pharma Inc.
XLRN
$13.5M 7.57% 254,923 – –
NTRA icon
7
Natera
NTRA
$23.1B
$7.03M 3.94% 208,768 -77,700 -27% -$2.62M
REPL icon
8
Replimune Group
REPL
$422M
$4.51M 2.52% 313,922 -255,740 -45% -$3.67M
CBAY
9
DELISTED
Cymabay Therapeutics
CBAY
$2.95M 1.65% 1,504,710 -3,381 -0.2% -$6.63K
ASND icon
10
Ascendis Pharma
ASND
$11.8B
$1.94M 1.09% 13,922 -190,166 -93% -$26.5M
BPMC
11
DELISTED
Blueprint Medicines
BPMC
– – -559,381 Closed -$41.1M
AIMT
12
DELISTED
Aimmune Therapeutics, Inc.
AIMT
– – -611,893 Closed -$12.8M
ALDR
13
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
– – -2,393,612 Closed -$45.1M
BHVN
14
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– – -53,345 Closed -$2.23M